Skip to main content

Barwon Health / Research

(03) 4215 0000

Intensive Care

Barwon Health's Intensive Care Unit (ICU) is a 24-bed unit with an active profile in clinical research. Research is an integral component of the Intensive Care Unit at Barwon Health.  It ensures we continually understand how best to treat patients and adapt to changes in health science. Conducting research in the critically ill requires particular skill, experience and sensitivity.  Our dedicated and experienced ICU research nurses are a pivotal interface between clinicians, patients, families, coordinating centres and hospital research governance processes. Research in ICU involves all disciplines and has grown significantly over the last 20 years.

Barwon Health ICU is a member of the Australian and New Zealand Intensive Care Society – Clinical Trials Group (ANZICS-CTG), and also conducts research that ranges from multi-centre clinical trials to observational studies.

Research Areas

Collaborating Organisations

 Deakin University

Monash University  University of Adelaide 

 La Trobe University

Australia & New Zealand Intensive Care Society – Clinical Trials Group

College of Intensive Care Medicine

 South Australian Health and Medical Research Institute 

Australia & New Zealand Intensive Care Society – Research Centre The George Institute for Global Health 

 

Research Team

Research staff

  • Dr Matthew Maiden, Head of ICU Research
  • Dr Claire Cattigan, Director ICU
  • A/Prof Neil Orford, Intensivist
  • Ms. Allison Bone, ICU Research Coordinator
  • Ms. Tania Salerno, ICU Research Nurse
  • Ms. Jemma Trickey, ICU Research Nurse

Research Students

  • Allison Bone, Doctor of Nursing (in progress), LaTrobe University: An exploration of the lived experience of haematological malignancy and critical illness

Featured Publications

Long-Term Outcomes Following Severe Traumatic Brain Injury in Older Adults: A Registry-Based Cohort Study. (NOTE – Abstract only. Staff can request full text from Library). Maiden MJ, Cameron PA, Rosenfeld JV, Cooper DJ, McLellan S, Gabbe BJ. Am J Respir Crit Care Med. 2020 Jan;201(2):167-177. (Journal Impact Factor 16.5)

 
 
Structure and Function of the Kidney in Septic Shock: A Prospective Controlled Experimental Study. Maiden MJ, Otto S, Brealey JK, Finnis ME, Chapman MJ, Kuchel TR, Nash CH, Edwards J, Bellomo R. Am J Respir Crit Care Med. 2016 Sep;194(6):692-700. (Journal Impact Factor 13.2) 
 
 
 
Changes in Bone Mineral Density in the Year After Critical Illness. Orford NR, Lane SE, Bailey M, Pasco JA, Cattigan C, Elderkin T, Brennan-Olsen SL, Bellomo R, Cooper DJ, Kotowicz MA. Am J Respir Crit Care Med. 2016 Apr;193(7):736-44. (Journal Impact Factor 13.2) 
 
 
 
How doctors discuss major interventions with high risk patients: an observational study. Corke CF, Stow PJ, Green DT, Agar JW, Henry MJ. BMJ. 2005 Jan 22;330(7484):182. (Journal Impact Factor: 9.1)
 
 
 
Triiodothyronine Administration in a Model of Septic Shock: A Randomized Blinded Placebo-Controlled Trial. [NOTE - Full text for Barwon Health staff; public can view abstract]. Maiden MJ, Chapman MJ, Torpy DJ, Kuchel TR, Clarke IJ, Nash CH, Fraser JD, Ludbrook GL. Crit Care Med 2016 Jun;44(6):1153-1160. (Journal Impact Factor: 7.1) 
 
 
 
Haemoglobin concentration and volume of intravenous fluids in septic shock in the ARISE trial. Maiden MJ, Finnis ME, Peake S, McRae S, Delaney A, Bailey M, Bellomo R. Crit Care. 2018 May;22(1):118. (Journal Impact Factor:7.0) 
 
 
 
The association of time and medications with changes in bone mineral density in the 2 years after critical illness. Orford NR, Bailey M, Bellomo R, Pasco JA, Cattigan C, Elderkin T, Brennan-Olsen SL, Cooper DJ, Kotowicz MA. Crit Care. 2017 Mar;21(1):69. (Journal Impact Factor 6.4) 
 
 
 
Skeletal morbidity among survivors of critical illness. [NOTE - Full text for Barwon Health staff; public can view abstract]. Orford NR, Saunders K, Merriman E, Henry M, Pasco J, Stow P, Kotowicz M. Crit Care Med. 2011 Jun;39(6) 1295-300. (Journal Impact Factor 6.3) 
 
 

Obstetric admissions to intensive care units in Australia and New Zealand: a registry-based cohort study. [NOTE - Full text for Barwon Health staff; public can view abstract]. Maiden MJ, Finnis ME, Duke GJ, Huning E, Crozier T, Nguyen N, Biradar V, McArthur C, Pilcher D. BJOG. 2020 May 2. Ahead of Print. (Journal Impact Factor: 5.2)

 
The association between critical illness and changes in bone turnover in adults: a systematic review. Orford N, Cattigan C, Brennan SL, Kotowicz M, Pasco J, Cooper DJ. Osteoporos Int. 2014 Oct;25(10):2335-46. (Journal Impact Factor 4.2) 
 
 
 

Support Our Research

Participate in a Clinical Trial

To find out about clinical trials currently underway at Barwon Health, click here

Donate

Clinical trials require ongoing investment and there are several ways to support this amazing work.

You can make a donation today and contribute to an item on our research wish list, consider a bequest in your will, or establish a lasting legacy fund in your name. No matter what size, your philanthropic support with deliver an immediate impact.

To donate now or for more information and further discuss your support, please contact the Barwon Health Foundation.

Wish  List

  1. $2,000 will fund the purchase of IT software for data analysis and data presentation
  2. $5,000 will fund a -80 degrees freezer for storing biological samples
  3. $50,000 will fund the Project Coordinator who is essential to conducting of a planned Patient Related Outcomes Study.

All Publications

 

Last Modified: Monday, 03 August 2020

Research Lead

Matt Maiden.png

Dr Matthew Maiden, BMBS, PhD

Intensive Care Staff Specialist
Head of ICU Research
University Hospital Geelong, Level 4
Bellerine Street, Geelong 3220
Phone (03) 4215 1729